760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors
Main Authors: | Kim Margolin, Victoria Atkinson, Charlotte Lemech, Philippe Bedard, Przemyslaw Twardowski, Sajeve Thomas, Amy Prawira, Arash Yavari, Peter Lloyd, Warren Brenner, Rosemina Merchant, Carole Galligan, Fahar Merchant, Minh D To, Melissa Coello, Jesus Fuentes Antras, Sudhir Madduri Karanam, Matthen Mathew |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1071 Characterization of a tumor-targeting and activatable T-MASK platform to enhance tumor accumulation and tolerability of potent immune modulators
by: Rosemina Merchant, et al.
Published: (2023-11-01) -
Memory-Based Deep Neural Attention (mDNA) for Cognitive Multi-Turn Response Retrieval in Task-Oriented Chatbots
by: Jenhui Chen, et al.
Published: (2020-08-01) -
On the Middle Asian taxa of the genus Melanargia Meigen, 1828 (Lepidoptera: Satyridae) with description of a new species and support of the Cox1 mDNA
by: S.K. Korb, et al.
Published: (2018-12-01) -
ORGN 760-Facile synthesis of 5,5-disubstituted hydantoins
by: Murray, R, et al.
Published: (2007) -
Association of multiple anthropometric indices with in 944,760 elderly Chinese people
by: Lirong Dong, et al.
Published: (2023-04-01)